About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
1 Dividend Stock to Buy for Passive Income in 2023
Healthcare giant Johnson & Johnson (JNJ) has a six-decade-long history of consecutive dividend growth. So, given the uncertainties surrounding the market, this fundamentally strong dividend-paying stock might be an ideal buy now. Read more...
1 Big Box Retailer Stock to Buy More of in 2023
Big box retailer Walmart (WMT) reported solid fourth-quarter results, topping analysts’ estimates. Moreover, WMT’s solid dividend-paying record makes it an attractive buy this year as macroeconomic uncertainties remain. Keep reading...
3 Consumer Stocks to Buy in 2023 and 1 to Sell Short
Consumers showing resiliency in the face of high inflation should bode well for the consumer goods sector. However, recession fears are still prevalent. While we think consumer stocks Unilever (UL), Ennis (EBF), and Mannatech (MTEX) might be ideal buys now, fundamentally weak Peloton Interactive (PTON) could be best sold short. Continue reading...
The 5 Safest Stocks You Can Buy in 2023
The stock market might remain volatile in the near term amid the still-alarmingly high inflation and the anticipated continuation of rate hikes. Therefore, fundamentally strong Eli Lilly (LLY), Novartis (NVS), Comcast (CMCSA), HCA Healthcare (HCA), and Myers Industries (MYE), which pay steady dividends, might be safe buys now. Read more...
Software Stocks for 2023: 1 to Buy and 2 to Avoid
Innovation in the software industry will likely continue bringing waves of investments. However, global economic instability is expected to compound near-term challenges for the software industry. While we think Salesforce (CRM) might be worth buying, fundamentally weak software stocks Robinhood Markets (HOOD) and Matterport (MTTR) could be best avoided. Keep reading...
1 Fertilizer Stock to Add to Your Watchlist in February 2023
The fertilizer industry is expected to witness stable demand this year, which should bode well for leading fertilizer company Mosaic (MOS). Moreover, the company is committed to growth with major expansion plans this year. So, it might be an ideal addition to your watchlist in February 2023. Read more...
1 Pharma Stock Poised for a Promising 2023
Following a year of solid growth in 2022, leading pharma company AstraZeneca’s (AZN) robust pipeline and recent launches look promising. Moreover, its strong fundamentals should enable the stock to deliver solid returns this year. So, AZN could be an ideal buy. Keep reading...
4 Dividend Stocks Yielding More Than 4% to Buy Without Hesitation
With inflation still alarmingly high, the Fed’s rate hikes might continue. This is raising concerns over the possibility of a recession. Therefore, quality dividend-paying stocks Altria (MO), International Paper (IP), ICL Group (ICL), and Spok (SPOK), yielding more than 4%, might be ideal buys now. Read more...
4 A-Rated Stocks to Buy Before the End of This Month
Sticky inflation might trigger more rate hikes this year, which could keep the stock market under pressure. Hence, investors could consider buying fundamentally strong stocks Stellantis (STLA), Honda Motor (HMC), MasterCraft Boat (MCFT), and Genie Energy (GNE) given the uncertainties. These stocks are rated A (Strong Buy) in our proprietary ratings system. Read more...